Literature DB >> 21786332

Cutoff level to detect heterozygous alpha 1 antitrypsin deficiency in Turkish population.

Halis Simsek1, Aslı Pinar, Akif Altinbas, Alparslan Alp, Yasemin H Balaban, Yahya Buyukasik, Osman Ozcebe, Gulsen Hascelik, Gokhan Gedikoglu, Gonca Tatar.   

Abstract

BACKGROUND: Alpha 1 antitrypsin (AT) deficiency is a hereditary disorder leading to the defective defence system against neutrophil elastasis in lung and accumulation of insoluble heterodimer AT molecules in hepatocytes. Knowledge of the prevalence of AT deficiency in each country is important to organize the public health policy. The aim of this study is to determine the prevalence of AT deficiency in Turkish population and to define the cutoff value of AT level in serum to detect heterozygous AT deficient subjects.
MATERIALS AND METHODS: Serum samples from 1,203 healthy blood donors were used, attending the Blood Bank of Hacettepe Medical Faculty. Isoelectric focusing method for determining PIM, PIS, and PIZ alleles and rate immune nephelometry for measuring the level of AT in serum were used.
RESULTS: Out of 1,203 healthy blood donors enrolled, 1,164 (%96.8) had normal variant PI MM allelee, 9 (%0.7) PI MZ, 7 (%0.6) PI MS, 6 (%0.5) MF, and 17 (%1.4) PI M? (unidentified variants with existing standards). Most individuals (89.6%) with low AT level (cutoff <100 mg/dl) in serum were positive for PI MM allele. The cutoff value to investigate PI MZ was 100.5 mg/dl, which had PPV and NPV of 5.0 and 99.9%, respectively. AT deficiency is a rare hereditary disorder in asymptomatic healthy Turkish blood donors. Although the cutoff value of 100.5 mg/dl for AT level in serum was able to detect heterozygous AT deficiency in the healthy population, this finding should be conformed to case-control studies.
© 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21786332      PMCID: PMC6647731          DOI: 10.1002/jcla.20472

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  15 in total

Review 1.  Alpha1-antitrypsin deficiency--a model for conformational diseases.

Authors:  Robin W Carrell; David A Lomas
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

2.  Genetic variants of alpha 1-antitrypsin and hemoglobin typed by isoelectric focusing in preselected narrow pH gradients with PhastSystem.

Authors:  J O Jeppsson; R Einarsson
Journal:  Clin Chem       Date:  1992-04       Impact factor: 8.327

3.  The cut-off value of 100 mg/dl is insufficient to detect heterozygous alpha-1 antitrypsin-deficient liver disease patients.

Authors:  Karin F Kok; Hans L Willems; Joost P H Drenth
Journal:  Liver Int       Date:  2009-11-30       Impact factor: 5.828

Review 4.  Molecular pathogenesis of liver disease in alpha1-antitrypsin deficiency.

Authors:  J H Teckman; D Qu; D H Perlmutter
Journal:  Hepatology       Date:  1996-12       Impact factor: 17.425

5.  Typing of genetic variants of alpha 1-antitrypsin by electrofocusing.

Authors:  J O Jeppsson; B Franzén
Journal:  Clin Chem       Date:  1982-01       Impact factor: 8.327

Review 6.  Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys.

Authors:  Frederick J de Serres
Journal:  Chest       Date:  2002-11       Impact factor: 9.410

7.  Prevalence of genetic polymorphisms in the promoter region of the alpha-1 antitrypsin (SERPINA1) gene in chronic liver disease: a case control study.

Authors:  Karin F Kok; René H te Morsche; Martijn G H van Oijen; Joost P H Drenth
Journal:  BMC Gastroenterol       Date:  2010-02-20       Impact factor: 3.067

8.  Serum levels of alpha1-antitrypsin predict phenotypic expression of the alpha1-antitrypsin gene.

Authors:  Steven J Steiner; Sandeep K Gupta; Joseph M Croffie; Joseph F Fitzgerald
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

Review 9.  Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review.

Authors:  K F Kok; P J Wahab; R H J Houwen; J P H Drenth; R A de Man; B van Hoek; J W R Meijer; F L A Willekens; R A de Vries
Journal:  Neth J Med       Date:  2007-05       Impact factor: 1.422

10.  Environmental, occupational, and genetic risk factors for alpha-1 antitrypsin deficiency.

Authors:  Richard R Sharp; Frederick de Serres; Lee Newman; Robert A Sandhaus; John W Walsh; Ernie Hood; G Jean Harry
Journal:  Environ Health Perspect       Date:  2003-11       Impact factor: 9.031

View more
  2 in total

Review 1.  Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis.

Authors:  Timm Greulich; Claus F Vogelmeier
Journal:  Ther Adv Respir Dis       Date:  2015-09-04       Impact factor: 4.031

2.  Alpha-1 antitrypsin deficiency in Iranian patients with chronic obstructive pulmonary disease.

Authors:  Bita Geramizadeh; Zahra Jowkar; Leila Karami; Masoum Masoumpour; Samrad Mehrabi; Mohammad-Ali Ghayoumi
Journal:  Iran Red Crescent Med J       Date:  2013-11-05       Impact factor: 0.611

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.